Larimar Therapeutics, Inc.
Support and Resistance Levels
Past performance
News About LRMR
All events for LRMR
All deals for LRMR
Financial Ratios
Financial Statements
LRMR vs Sector & Peers
About Larimar Therapeutics, Inc.
Headquartered in Bala Cynwyd, Pennsylvania, Larimar Therapeutics, Inc. operates as a clinical-stage biotechnology firm. Its core mission involves crafting therapies for rare diseases, leveraging a distinctive cell-penetrating peptide technology platform. The company's foremost experimental therapy, CTI-1601, is presently undergoing Phase 1 clinical trials. This drug candidate is being developed to combat Friedreich's ataxia, a genetic illness that is rare, relentlessly progressive, and ultimately fatal. Website larimartx.com
Headquarters Bala Cynwyd, PA, US